Publications 2025

Lamsal A, Andersen SB, Nonstad U, Kurganovs NJ, Skipworth RJ, Bjørkøy G, Pettersen K (2025)
A role of arginase-1-expressing myeloid cells in cachexia
Cancer Metab, 13 (1), 27
DOI 10.1186/s40170-025-00396-0, PubMed 40474277

Lamsal A, Andersen SB, Nonstad U, Kurganovs NJ, Skipworth RJ, Bjørkøy G, Pettersen K (2025)
Correction: A role of arginase-1-expressing myeloid cells in cachexia
Cancer Metab, 13 (1), 44
DOI 10.1186/s40170-025-00412-3, PubMed 41204350

Yamaguchi TN, Houlahan KE, Zhu H, Kurganovs N, Livingstone J, Fox NS, Yuan J, Sietsma Penington J, Jung CH, Schwarz T, Jaratlerdsiri W, van Riet J, Georgeson P, Mangiola S, Taraszka K, Lesurf R, Jiang J, Chow K, Heisler LE, Shiah YJ, Ramanand SG, Clarkson MJ, Nguyen A, Espiritu SMG, Stuchbery R et al. (2025)
The Germline and Somatic Origins of Prostate Cancer Heterogeneity
Cancer Discov, 15 (5), 988-1017
DOI 10.1158/2159-8290.CD-23-0882, PubMed 39945744

Publications 2024

Haas R, Frame G, Khan S, Neilsen BK, Hong BH, Yeo CPX, Yamaguchi TN, Ong EHW, Zhao W, Carlin B, Yeo ELL, Tan KM, Bugh YZ, Zhu C, Hugh-White R, Livingstone J, Poon DJJ, Chu PL, Patel Y, Tao S, Ignatchenko V, Kurganovs NJ, Higgins GS, Downes MR, Loblaw A et al. (2024)
The Proteogenomics of Prostate Cancer Radioresistance
Cancer Res Commun, 4 (9), 2463-2479
DOI 10.1158/2767-9764.CRC-24-0292, PubMed 39166898

Kurganovs NJ, Engedal N (2024)
To eat or not to eat: a critical review on the role of autophagy in prostate carcinogenesis and prostate cancer therapeutics
Front Pharmacol, 15, 1419806
DOI 10.3389/fphar.2024.1419806, PubMed 38910881

Publications 2023

Houlahan KE, Livingstone J, Fox NS, Kurganovs N, Zhu H, Sietsma Penington J, Jung CH, Yamaguchi TN, Heisler LE, Jovelin R, Costello AJ, Pope BJ, Kishan AU, Corcoran NM, Bristow RG, Waszak SM, Weischenfeldt J, He HH, Hung RJ, Hovens CM, Boutros PC (2023)
A polygenic two-hit hypothesis for prostate cancer
J Natl Cancer Inst, 115 (4), 468-472
DOI 10.1093/jnci/djad001, PubMed 36610996

Lamsal A, Andersen SB, Johansson I, Vietri M, Bokil AA, Kurganovs NJ, Rylander F, Bjørkøy G, Pettersen K, Giambelluca MS (2023)
Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer
Cell Commun Signal, 21 (1), 50
DOI 10.1186/s12964-023-01062-y, PubMed 36882786

Publications 2021

Cmero M, Kurganovs NJ, Stuchbery R, McCoy P, Grima C, Ngyuen A, Chow K, Mangiola S, Macintyre G, Howard N, Kerger M, Dundee P, Ruljancich P, Clarke D, Grummet J, Peters JS, Costello AJ, Norden S, Ryan A, Parente P, Hovens CM, Corcoran NM (2021)
Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy
JCO Precis Oncol, 5
DOI 10.1200/PO.20.00337, PubMed 34322653

Kurganovs N, Wang H, Huang X, Ignatchenko V, Macklin A, Khan S, Downes MR, Boutros PC, Liu SK, Kislinger T (2021)
A proteomic investigation of isogenic radiation resistant prostate cancer cell lines
Proteomics Clin Appl, 15 (5), e2100037
DOI 10.1002/prca.202100037, PubMed 34152685

McCoy P, Mangiola S, Macintyre G, Hutchinson R, Tran B, Pope B, Georgeson P, Hong MKH, Kurganovs N, Lunke S, Clarkson MJ, Cmero M, Kerger M, Stuchbery R, Chow K, Haviv I, Ryan A, Costello AJ, Corcoran NM, Hovens CM (2021)
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer
Prostate Cancer Prostatic Dis, 24 (4), 1167-1180
DOI 10.1038/s41391-021-00379-4, PubMed 34108644

Publications 2019

Mangiola S, Stuchbery R, McCoy P, Chow K, Kurganovs N, Kerger M, Papenfuss A, Hovens CM, Corcoran NM (2019)
Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat
Endocr Connect, 8 (5), 547-558
DOI 10.1530/EC-19-0029, PubMed 30959474

Sinha A, Huang V, Livingstone J, Wang J, Fox NS, Kurganovs N, Ignatchenko V, Fritsch K, Donmez N, Heisler LE, Shiah YJ, Yao CQ, Alfaro JA, Volik S, Lapuk A, Fraser M, Kron K, Murison A, Lupien M, Sahinalp C, Collins CC, Tetu B, Masoomian M, Berman DM, van der Kwast T et al. (2019)
The Proteogenomic Landscape of Curable Prostate Cancer
Cancer Cell, 35 (3), 414-427.e6
DOI 10.1016/j.ccell.2019.02.005, PubMed 30889379

Publications 2018

Atkins RJ, Stylli SS, Kurganovs N, Mangiola S, Nowell CJ, Ware TM, Corcoran NM, Brown DV, Kaye AH, Morokoff A, Luwor RB, Hovens CM, Mantamadiotis T (2018)
Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance
Exp Cell Res, 374 (2), 353-364
DOI 10.1016/j.yexcr.2018.12.010, PubMed 30562483

Publications 2017

Hovens MC, Lo K, Kerger M, Pedersen J, Nottle T, Kurganovs N, Ryan A, Peters JS, Moon D, Costello AJ, Corcoran NM, Hong MKH (2017)
3D modelling of radical prostatectomy specimens: Developing a method to quantify tumor morphometry for prostate cancer risk prediction
Pathol Res Pract, 213 (12), 1523-1529
DOI 10.1016/j.prp.2017.09.022, PubMed 29033190

Publications 2016

Mangiola S, Hong MK, Cmero M, Kurganovs N, Ryan A, Costello AJ, Corcoran NM, Macintyre G, Hovens CM (2016)
Comparing nodal versus bony metastatic spread using tumour phylogenies
Sci Rep, 6, 33918
DOI 10.1038/srep33918, PubMed 27653089

Publications 2015

Hong MK, Macintyre G, Wedge DC, Van Loo P, Patel K, Lunke S, Alexandrov LB, Sloggett C, Cmero M, Marass F, Tsui D, Mangiola S, Lonie A, Naeem H, Sapre N, Phal PM, Kurganovs N, Chin X, Kerger M, Warren AY, Neal D, Gnanapragasam V, Rosenfeld N, Pedersen JS, Ryan A et al. (2015)
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
Nat Commun, 6, 6605
DOI 10.1038/ncomms7605, PubMed 25827447

Stuchbery R, Kurganovs NJ, McCoy PJ, Nelson CC, Hayes VM, Corcoran NM, Hovens CM (2015)
Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer
Curr Cancer Drug Targets, 15 (5), 394-405
DOI 10.2174/1568009615666150416113453, PubMed 25882061